公司資料
Amylyx 股價、新聞與催化劑
- 股票代碼:
- AMLX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
21.43 USD (-0.92%)
收盤價
最後更新: 2026年8月17日
1.48B USD
市值
股價為何變動
As of Aug 17, 2026, AMLX closed down 0.92% at $21.43. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Amylyx is a neuroscience company that has shifted after Relyvrio toward a broader rare-disease and neurodegeneration pipeline.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Amylyx sits in specialty neuroscience biotech.
商業模式特徵
The company now depends on pipeline execution, data credibility, and rebuilding investor confidence after a major product reset.
生技產業定位
Amylyx remains a headline-sensitive CNS name because the market is still reassessing its long-term story.
未來催化劑
- Amylyx's catalysts are AMX0114 and the post-Relyvrio pipeline reset, which need to show the company still has a credible neuroscience path. The next update matters because the story is still being rebuilt.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。